
Acelyrin, Inc. (Nasdaq: SLRN), relating to the proposed merger with Alumis Inc. Under the terms of the agreement, Acelyrin stockholders will receive 0.4274 shares of Alumis common stock per share of common stock owned. Upon the close of the transaction, Acelyrin stockholders will own approximately 45% of the combined company.